-
1
-
-
0028829472
-
Recent advances in pathogenesis, diagnosis, and management of acromegaly
-
Melmed S., Ho K., Klibanski A., Reichlin S., Thomer M. Recent advances in pathogenesis, diagnosis, and management of acromegaly. J. Clin. Endocrinol. Metab. 80: 3395, 1995.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 3395
-
-
Melmed, S.1
Ho, K.2
Klibanski, A.3
Reichlin, S.4
Thomer, M.5
-
2
-
-
0018637119
-
Evaluation of acromegaly by radioimmunoassay of Somatomedin C
-
Clemmons D., Van Wyk J., Ridgway E., Kliman B., Kjellberg R., Underwood L. Evaluation of acromegaly by radioimmunoassay of Somatomedin C. N. Engl. J. Med. 301: 1138, 1979.
-
(1979)
N. Engl. J. Med.
, vol.301
, pp. 1138
-
-
Clemmons, D.1
Van Wyk, J.2
Ridgway, E.3
Kliman, B.4
Kjellberg, R.5
Underwood, L.6
-
3
-
-
0022405750
-
Acromegaly: Biochemical assessment of cure after long-term follow-up of transsphenoidal selective adenomectomy
-
Serri O., Somma M., Comtois R., Rasio E., Beauregard H., Jilwan N., Hardy J. Acromegaly: biochemical assessment of cure after long-term follow-up of transsphenoidal selective adenomectomy. J. Clin. Endocrinol. Metab. 61: 1185, 1985.
-
(1985)
J. Clin. Endocrinol. Metab.
, vol.61
, pp. 1185
-
-
Serri, O.1
Somma, M.2
Comtois, R.3
Rasio, E.4
Beauregard, H.5
Jilwan, N.6
Hardy, J.7
-
4
-
-
0025143154
-
Use of insulin like growth factor-binding protein 3 for the evaluation of growth disorders
-
Blum W., Ranke M. Use of insulin like growth factor-binding protein 3 for the evaluation of growth disorders. Horm. Res. 33 (Suppl. 4): 31, 1990.
-
(1990)
Horm. Res.
, vol.33
, Issue.SUPPL. 4
, pp. 31
-
-
Blum, W.1
Ranke, M.2
-
5
-
-
0028904257
-
Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly
-
Grinspoon S., Clemmons D., Swearingen B., Klibanski A. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. J. Clin. Endocrinol. Metab. 80: 927, 1995.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 927
-
-
Grinspoon, S.1
Clemmons, D.2
Swearingen, B.3
Klibanski, A.4
-
6
-
-
0028823820
-
IGFBP3 is a poor parameter for assessment of clinical activity in acromegaly
-
de Herder W., van der Lely A., Janssen J., Vitterlinden P., Hofland L., Lamberts S. IGFBP3 is a poor parameter for assessment of clinical activity in acromegaly. Clin. Endocrinol. (Oxf.) 43: 501, 1995.
-
(1995)
Clin. Endocrinol. (Oxf.)
, vol.43
, pp. 501
-
-
De Herder, W.1
Van Der Lely, A.2
Janssen, J.3
Vitterlinden, P.4
Hofland, L.5
Lamberts, S.6
-
7
-
-
0028350642
-
Biochemical markers of acromegalic activity
-
Jasper H., Chervin A., Vitale M., Mella A., Ropelato G., Basso A. Biochemical markers of acromegalic activity. Medicina (Buenos Aires) 54: 25, 1994.
-
(1994)
Medicina (Buenos Aires)
, vol.54
, pp. 25
-
-
Jasper, H.1
Chervin, A.2
Vitale, M.3
Mella, A.4
Ropelato, G.5
Basso, A.6
-
8
-
-
0027954066
-
The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
-
Juul A., Main K., Blum W., Lindholm J., Ranke M., Skakkebek N. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin. Endocrinol. (Oxf.) 41: 85, 1994.
-
(1994)
Clin. Endocrinol. (Oxf.)
, vol.41
, pp. 85
-
-
Juul, A.1
Main, K.2
Blum, W.3
Lindholm, J.4
Ranke, M.5
Skakkebek, N.6
-
9
-
-
0019753097
-
Somatomedin C in treated acromegaly: Poor correlation with growth hormone and clinical response
-
Stonesifer L, Jordan R., Kohler P. Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response. J. Clin. Endocrinol. Metab. 53: 931, 1981.
-
(1981)
J. Clin. Endocrinol. Metab.
, vol.53
, pp. 931
-
-
Stonesifer, L.1
Jordan, R.2
Kohler, P.3
-
10
-
-
37049058783
-
A sensitive double antibody immunoassay for human growth hormone in plasma
-
Schalch D., Parker M. A sensitive double antibody immunoassay for human growth hormone in plasma. Nature 203: 1141, 1964.
-
(1964)
Nature
, vol.203
, pp. 1141
-
-
Schalch, D.1
Parker, M.2
-
11
-
-
0018959529
-
Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum
-
Daughaday W., Mariz I., Blethen S. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J. Clin. Endocrinol. Metab. 51: 781, 1980.
-
(1980)
J. Clin. Endocrinol. Metab.
, vol.51
, pp. 781
-
-
Daughaday, W.1
Mariz, I.2
Blethen, S.3
-
12
-
-
0025319339
-
A specific radioimmunoassay for the growth hormone-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency
-
Blum W., Ranke M., Kietzmann K., Gauggel E., Zeizel H., Bierich J. A specific radioimmunoassay for the growth hormone-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J. Clin. Endocrinol. Metab. 70: 1292, 1990.
-
(1990)
J. Clin. Endocrinol. Metab.
, vol.70
, pp. 1292
-
-
Blum, W.1
Ranke, M.2
Kietzmann, K.3
Gauggel, E.4
Zeizel, H.5
Bierich, J.6
-
13
-
-
0019787116
-
Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia
-
Zapf J., Walther H., Froesch E. Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J. Clin. Invest. 68: 1321, 1981 .
-
(1981)
J. Clin. Invest.
, vol.68
, pp. 1321
-
-
Zapf, J.1
Walther, H.2
Froesch, E.3
-
14
-
-
0022839490
-
Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
-
Baxter R., Martin J. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J. Clin. Invest. 73: 1504, 1986.
-
(1986)
J. Clin. Invest.
, vol.73
, pp. 1504
-
-
Baxter, R.1
Martin, J.2
-
15
-
-
0026467327
-
Serum IGF-binding protein-3 is related to IGF-I, but not to spontaneous GH release, in healthy old men
-
Corpas E., Harman S., Blackman M. Serum IGF-binding protein-3 is related to IGF-I, but not to spontaneous GH release, in healthy old men. Horm. Metab. Res. 24: 543, 1992.
-
(1992)
Horm. Metab. Res.
, vol.24
, pp. 543
-
-
Corpas, E.1
Harman, S.2
Blackman, M.3
-
16
-
-
0028221215
-
Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH producing pituitary tumors
-
Ho P., Jaffe C., Demott Friberg R., Chandler W., Barkan A. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH producing pituitary tumors. J. Clin. Endocrinol. Metab. 78: 1403, 1994.
-
(1994)
J. Clin. Endocrinol. Metab.
, vol.78
, pp. 1403
-
-
Ho, P.1
Jaffe, C.2
Demott Friberg, R.3
Chandler, W.4
Barkan, A.5
-
17
-
-
0028132941
-
Characterization of 24-hour growth hormone secretion in acromegaly: Implications for diagnosis and therapy
-
Ho K., Weissberger A. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clin. Endocrinol. (Oxf.) 47: 75, 1994.
-
(1994)
Clin. Endocrinol. (Oxf.)
, vol.47
, pp. 75
-
-
Ho, K.1
Weissberger, A.2
-
18
-
-
0025700486
-
Medical progress: Acromegaly
-
Melmed S. Medical progress: Acromegaly. N. Engl. J. Med. 322: 966, 1990.
-
(1990)
N. Engl. J. Med.
, vol.322
, pp. 966
-
-
Melmed, S.1
|